A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections-Reference-Cited by-同舟云学术

A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections

Published:2022-03-18 Issue:5 Volume:41 Page:761-769
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Demirlenk Yusuf Mert,Gücer Lal Sude,Uçku Duygu,Tanrıöver Cem,Akyol Merve,Kalay Zeynepgül,Barçın Erinç,Akcan Rüştü Emre,Can Füsun,Gönen Mehmet,Ergönül Önder

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-022-04429-0.pdf

Reference31 articles.

1. Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14(4):933–951, table of contents

2. Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D, Antibacterial resistance leadership G (2016) Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect 22(6):513–519

3. Aydin M, Ergonul O, Azap A, Bilgin H, Aydin G, Cavus SA, Demiroglu YZ, Aliskan HE, Memikoglu O, Menekse S, Kaya S, Demir NA, Karaoglan I, Basaran S, Hatipoglu C, Erdinc S, Yilmaz E, Tumturk A, Tezer Y, Demirkaya H, Cakar SE, Keske S, Tekin S, Yardimci C, Karakoc C, Ergen P, Azap O, Mulazimoglu L, Ural O, Can F, Akalin H, Turkish Society of Clinical M, Infectious Diseases H-rISGT (2018) Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. J Hosp Infect 98(3):260–263

4. Ergonul O, Aydin M, Azap A, Basaran S, Tekin S, Kaya S, Gulsun S, Yoruk G, Kursun E, Yesilkaya A, Simsek F, Yilmaz E, Bilgin H, Hatipoglu C, Cabadak H, Tezer Y, Togan T, Karaoglan I, Inan A, Engin A, Aliskan HE, Yavuz SS, Erdinc S, Mulazimoglu L, Azap O, Can F, Akalin H, Timurkaynak F, Turkish Society of Clinical M, Infectious Diseases H-RISG (2016) Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect 94(4):381–385

5. Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I, Papadomichelakis E, Kopterides P, Souli M, Armaganidis A, Giamarellou H (2007) Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 59(4):786–790

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of novel apramycin-dextran nanoparticles and free apramycin against selected Dutch and Pakistani Klebsiella pneumonia isolates;Heliyon;2023-12

2. Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections;Expert Review of Anti-infective Therapy;2022-09-28

3. Intestinal Colonization with Carbapenem-Resistant Enterobacteriaceae in Acute Leukemia Patients: Risk Factors and Molecular Characteristics;Infection and Drug Resistance;2022-08

4. Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report;Medicine;2022-07-29

5. Efficacy of Amikacin and Meropenem on Colistin-Induced Klebsiella pneumoniae Persisters;Microbial Drug Resistance;2022-07-01